HOT NEWS
Merck
Merck & Co., Inc.Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

Merck RSS Channel

Title Filter     Display # 
# Article Title Hits
1 European Union Approves MSD's New Single Dose 'Ivemend'® 11226
2 Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections 12320
3 New SIMPONI™ (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis 12904
4 New Study Shows Rheumatoid Arthritis Patients Report Need for Improvement in Subcutaneous Therapy Delivery Devices 12091
5 Merck Announces Launch of Pioneering Collaborative Cancer Trials Network 10572
6 Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology 13315
7 Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy 11642
8 Merck Announces First-Quarter 2010 Financial Results 10162
9 Merck Receives European Approval for ELONVA® (corifollitropin alfa injection) 16298
10 New Merck Begins Operations 10653
11 Merck and Schering-Plough to Merge 5100
12 Pivotal Study Evaluating Efficacy of GARDASIL 3229
13 Merck Reaffirms Cardiovascular Research Commitment 3268